ES2549189B2 - Composición para el tratamiento de la alopecia masculina - Google Patents

Composición para el tratamiento de la alopecia masculina Download PDF

Info

Publication number
ES2549189B2
ES2549189B2 ES201430596A ES201430596A ES2549189B2 ES 2549189 B2 ES2549189 B2 ES 2549189B2 ES 201430596 A ES201430596 A ES 201430596A ES 201430596 A ES201430596 A ES 201430596A ES 2549189 B2 ES2549189 B2 ES 2549189B2
Authority
ES
Spain
Prior art keywords
treatment
composition
male alopecia
alopecia
male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201430596A
Other languages
English (en)
Other versions
ES2549189A1 (es
Inventor
Fermín CRESPO RODRÍGUEZ
María Asunción SÁNCHEZ GARCÍA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES201430596A priority Critical patent/ES2549189B2/es
Publication of ES2549189A1 publication Critical patent/ES2549189A1/es
Application granted granted Critical
Publication of ES2549189B2 publication Critical patent/ES2549189B2/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición para el tratamiento de la alopecia masculina. Se describe una composición que se administra por vía oral para el tratamiento de la alopecia masculina. Las composiciones comprenden aminoácidos, oligoelementos, metilsulfona, colina, cistina y un inhibidor de la 5 -alfa- reductasa. Mediante las composiciones descritas se evita el trasplante capilar.
ES201430596A 2014-04-22 2014-04-22 Composición para el tratamiento de la alopecia masculina Expired - Fee Related ES2549189B2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201430596A ES2549189B2 (es) 2014-04-22 2014-04-22 Composición para el tratamiento de la alopecia masculina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430596A ES2549189B2 (es) 2014-04-22 2014-04-22 Composición para el tratamiento de la alopecia masculina

Publications (2)

Publication Number Publication Date
ES2549189A1 ES2549189A1 (es) 2015-10-23
ES2549189B2 true ES2549189B2 (es) 2016-09-15

Family

ID=54325826

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201430596A Expired - Fee Related ES2549189B2 (es) 2014-04-22 2014-04-22 Composición para el tratamiento de la alopecia masculina

Country Status (1)

Country Link
ES (1) ES2549189B2 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
GB9706318D0 (en) * 1997-03-26 1997-05-14 Bryant Andrew E Therapeutic formulations
US7452527B2 (en) * 2003-03-28 2008-11-18 Murad, Inc. Methods of promoting hair growth
MXPA06009979A (es) * 2004-03-02 2007-03-01 Giuliani Spa Composicion para regular el trofismo de foliculos pilosos y la produccion cutanea de sebo y el uso del mismo en alopecia androgenica.
CN102698273A (zh) * 2004-12-24 2012-10-03 都菲斯特股份有限公司 毛发学制剂和毛发学治疗
GB2461021A (en) * 2008-06-10 2009-12-23 Ajit Lalvani Composition for the treatment of hair loss and baldness
US20110256239A1 (en) * 2010-04-15 2011-10-20 Shapiro Lawrence J Ingestible hair and finger nail growth promoter and method

Also Published As

Publication number Publication date
ES2549189A1 (es) 2015-10-23

Similar Documents

Publication Publication Date Title
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
CL2018001230A1 (es) Tratamiento de osteoartritis
DOP2017000151A (es) Derivados de quinazolina utilizados para tratar el vih
ECSP17070706A (es) Inhibidores de bromodominio
SV2018005775A (es) Forma polimorfa de n-{6-(2-hidroxipropan-2-il)-2-[2-(metilsulfonil)etil]-2h-indazol-5-il}-6-(trifluorometil)piridin-2- carboxamida
CO2017001884A2 (es) Polimorfos de selinexor
SV2018005621A (es) Inhibidor de la isocitrato deshidrogenasa mutada idh1 r132h
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
CL2017000715A1 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo
CL2016002338A1 (es) Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática .
UY36920A (es) Formulaciones de aminoácidos de liberación modificada administradas por vía oral
BR112017000730A2 (pt) derivados de pirrolidinona como inibidores de metap-2
UY36221A (es) Derivados de isoindolinona
CR20160448A (es) Nuevos derivados de piridina
BR112017025427A2 (pt) composição farmacêutica oral
EA201790275A1 (ru) Кристаллические формы 6-((6,7-диметоксихиназолин-4-ил)окси)-n,2-диметилбензофуран-3-карбоксамида
CL2018001493A1 (es) Nuevos derivados de fenilo
BR112017007860A2 (pt) método para tratar uma doença de gordura no fígado
CY1123877T1 (el) Μορφες στερεας καταστασης αλατων νιλοτινιμπης
CL2018002149A1 (es) Proceso.
DK3402573T3 (da) Aminosyreholdig sammensætning
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
BR112017012811A2 (pt) novo tratamento para doenças hepáticas gordurosas não alcoólicas
ES2549189B2 (es) Composición para el tratamiento de la alopecia masculina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2549189

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20160915

FD2A Announcement of lapse in spain

Effective date: 20220630